Clinical Trial Update: Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating proteinuria and renal function in non-diabetic patients with progressive renal disease has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperlipidemia

Snippet

Sponsor: AstraZeneca | Conditions: Hyperlipidemia | Phase 2 | Status: COMPLETED | Results posted: 2010-12-30